43858 The 31-gene expression profile test for cutaneous melanoma identifies patients with stage IB- IIA disease who have recurrence risk similar to that of stage IIB-IIC disease
Year: 2023
Type: article
Study design: Observational Study
Institution: Castle Biosciences, Inc. (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Castle Biosciences
OpenAlex ID: W4387026257
